Delivery and fate of oral mesalamine microgranules within the human small intestine
- 1 May 1995
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 108 (5), 1427-1433
- https://doi.org/10.1016/0016-5085(95)90691-6
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Medical therapy of ulcerative colitisThe Lancet, 1993
- Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's diseaseDigestive Diseases and Sciences, 1992
- Topical and systemic availability of 5‐amino‐salicylate: comparisons of three controlled release preparations in manAlimentary Pharmacology & Therapeutics, 1990
- Pharmacokinetics of a 5‐aminosalicylic acid enteric‐coated tablet in patients with Crohn's disease or ulcerative colitis and in healthy volunteersAlimentary Pharmacology & Therapeutics, 1990
- Coated oral 5‐aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's diseaseAlimentary Pharmacology & Therapeutics, 1990
- Mesalazine A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Chronic Inflammatory Bowel DiseaseDrugs, 1989
- Pharmacokinetics of a 5‐aminosalicylic acid enteric‐coated tablet and suppository dosage formAlimentary Pharmacology & Therapeutics, 1989
- Newer 5-Aminosalicylic Acid Based Drugs in Chronic Inflammatory Bowel DiseaseDrugs, 1989
- Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic AcidClinical Pharmacokinetics, 1985
- A comparison of stable and 14C-labelled polyethylene glycol as volume indicators in the human jejunumGut, 1972